Fused heterocyclic compounds as ion channel modulators
US9115096B2 · kind B2 · utility
5Cited by
31References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2012 |
| Grant date | Aug 25, 2015 |
| Priority date | — |
| Expiry date | Dec 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I:wherein Q, R1, X1, X2, Y and R2 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.